An epidemiological study to assess Plasmodium falciparum parasite prevalence and malaria control measures in Burkina Faso and Senegal

Malaria Journal

Volumn 16, Issue 1, 2017, Pages 1-12

  Diallo, Aldiouma ^a   Sié, Ali ^b   Sirima, Sodiomon ^c   Sylla, Khadime ^d   Ndiaye, Mahmadou ^a   Bountogo, Mamadou ^b   Ouedraogo, Espérance ^c   Tine, Roger ^d   Ndiaye, Assane ^a   Coulibaly, Boubacar ^b   Ouedraogo, Alphonse ^c   Faye, Babacar ^d   Ba, El Hadji ^a   Compaore, Guillaume ^b   Tiono, Alfred ^c   Sokhna, Cheikh ^a   Yé, Maurice ^b   Diarra, Amidou ^c   Bahmanyar, Edith Roset ^e   De Boer, Melanie ^f   Pirçon, Jean Yves ^f   Usuf, Effua Abigail ^f   more..

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^b CENTRE DE RECHERCHE EN SANTÉ DE NOUNA   (Burkina Faso)

^c Burkina Faso   (Burkina Faso)

^d UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^e Profa Foundation   (Switzerland)

^f GSK   (Belgium)

Author keywords

Burkina Faso; Epidemiological study; Malaria; Parasite prevalence; Preventive interventions; Risk factors; Senegal

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; DIHYDROARTEMISININ PLUS PIPERAQUINE;

ARTICLE; BLOOD SAMPLING; BURKINA FASO; CHILD; CHILD HOSPITALIZATION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; FEVER; GAMETOCYTE; HUMAN; INFANT; MALARIA; MALARIA CONTROL; MALARIA RAPID TEST; MALE; PARASITE PREVALENCE; PLASMODIUM FALCIPARUM; POPULATION RESEARCH; RURAL AREA; SENEGAL; SEX RATIO; TREATMENT DURATION; URBAN AREA; ANIMAL; CLASSIFICATION; COMMUNICABLE DISEASE CONTROL; DISEASE TRANSMISSION; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; PLASMODIUM; PRESCHOOL CHILD; PREVALENCE; PREVENTION AND CONTROL; PROCEDURES;

ANIMALS; BURKINA FASO; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; CROSS-SECTIONAL STUDIES; DISEASE TRANSMISSION, INFECTIOUS; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PLASMODIUM; PREVALENCE; SENEGAL;

EID: 85011586065     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-017-1715-1     Document Type: Article

References (30)

1. WHO. Malaria vaccine: WHO position paper. Wkly Epidemiol Rec. 2016;91:33-51.
2. WHO. World malaria report. Geneva: World Health Organization; 2014. http://www.who.int/malaria/publications/world_malaria_report_2014/report/en/. Accessed 23 May 2016.
3. Meeting of the Strategic Advisory Group of Experts on Immunization. Conclusions and recommendations. Wkly Epidemiol Rec. 2015;2015(90):681-99.
4. The RTS,S Clinical Trials Partnership. Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014;11:e1001685.
5. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455-67.
6. Noor AM, Kinyoki DK, Mundia CW, Kabaria CW, Mutua JW, Alegana VA, et al. The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity. Lancet. 2014;383:1739-47.
7. Protopopoff N, Matowo J, Malima R, Kavishe R, Kaaya R, Wright A, et al. High level of resistance in the mosquito Anopheles gambiae to pyrethroid insecticides and reduced susceptibility to bendiocarb in north-western Tanzania. Malar J. 2013;12:149.
8. Breman JG. Eradicating malaria. Sci Prog. 2009;92(Pt 1):1-38.
9. Greenwood BM, Fidock DA, Kyle DE, Kappe SH, Alonso PL, Collins FH, et al. Malaria: progress, perils, and prospects for eradication. J Clin Invest. 2008;118:1266-76.
10. The RTS,S Clinical Trials Partnership. First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children. N Engl J Med. 2011;365:1863-75.
11. The RTS,S Clinical Trials Partnership. A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. N Engl J Med. 2012;367:2284-95.
12. The RTS,S Clinical Trials Partnership. Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386:31-45.
13. European Medicines Agency (EMA). First malaria vaccine receives positive scientific opinion from EMA. EMA/CHMP/488348/2015. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2015/07/WC500190447.pdf. Accessed 29 Feb 2016, 2015.
14. Diboulo E, Sie A, Diadier DA, Voules DA, Ye Y, Vounatsou P. Bayesian variable selection in modelling geographical heterogeneity in malaria transmission from sparse data: an application to Nouna Health and Demographic Surveillance System (HDSS) data, Burkina Faso. Parasit Vectors. 2015;8:118.
15. Geiger C, Agustar HK, Compaore G, Coulibaly B, Sie A, Becher H, et al. Declining malaria parasite prevalence and trends of asymptomatic parasitaemia in a seasonal transmission setting in North-Western Burkina Faso between 2000 and 2009-2012. Malar J. 2013;12:27.
16. Ilboudo-Sanogo E, Tiono BA, Sagnon N, Cuzin Ouattara N, Nebie I, Sirima SB. Temporal dynamics of malaria transmission in two rural areas of Burkina Faso with two ecological differences. J Med Entomol. 2010;47:618-24.
17. Ndiath M, Faye B, Cisse B, Ndiaye JL, Gomis JF, Dia AT, et al. Identifying malaria hotspots in Keur Soce health and demographic surveillance site in context of low transmission. Malar J. 2014;13:453.
18. Sylla K, Tine RC, Ndiaye M, Sow D, Sarr A, Mbuyi ML, et al. Sero-epidemiological evaluation of Plasmodium falciparum malaria in Senegal. Malar J. 2015;14:275.
19. Vafa M, Troye-Blomberg M, Anchang J, Garcia A, Migot-Nabias F. Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants. Malar J. 2008;7:17.
20. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJ, et al. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet. 2008;372:1545-54.
21. Ouedraogo AL, Bousema T, Schneider P, de Vlas SJ, Ilboudo-Sanogo E, Cuzin-Ouattara N, et al. Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. PLoS ONE. 2009;4:e8410.
22. Tine RCK, Faye B, Ndour CT, Sylla K, Sow D, Ndiaye M, et al. Parasitic infections among children under 5 years in Senegal: prevalence and effect on anaemia and nutritional status. ISRN Parasitol. 2013;2013:272701.
23. Ouedraogo A, Tiono AB, Diarra A, Sanon S, Yaro JB, Ouedraogo E, et al. Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso. PLoS ONE. 2013;8:e50036.
24. Lindsay S, Ansell J, Selman C, Cox V, Hamilton K, Walraven G. Effect of pregnancy on exposure to malaria mosquitoes. Lancet. 2000;355:1972.
25. Verhulst NO, Qiu YT, Beijleveld H, Maliepaard C, Knights D, Schulz S, et al. Composition of human skin microbiota affects attractiveness to malaria mosquitoes. PLoS ONE. 2011;6:e28991.
26. Gnémé A, Guelbéogo WM, Riehle MM, Tiono AB, Diarra A, Kabré GB, et al. Plasmodium species occurrence, temporal distribution and interaction in a child-aged population in rural Burkina Faso. Malar J. 2013;12:67.
27. Tiono AB, Kangoye DT, Rehman AM, Kargougou DG, Kabore Y, Diarra A, et al. Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods. PLoS ONE. 2014;9:e86936.
28. Louis VR, Schoeps A, Tiendrebeogo J, Beiersmann C, Ye M, Damiba MR, et al. An insecticide-treated bed-net campaign and childhood malaria in Burkina Faso. Bull World Health Organ. 2015;93:750-8.
29. Ntonifor NN, Ngufor CA, Kimbi HK, Oben BO. Traditional use of indigenous mosquito-repellents to protect humans against mosquitoes and other insect bites in a rural community of Cameroon. East African Med J. 2006;83:553-8.
30. Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237.